[go: up one dir, main page]

EE04344B1 - Telmisartan polymorphs, methods for their preparation and their use in the preparation of a medicament - Google Patents

Telmisartan polymorphs, methods for their preparation and their use in the preparation of a medicament

Info

Publication number
EE04344B1
EE04344B1 EEP200100375A EEP200100375A EE04344B1 EE 04344 B1 EE04344 B1 EE 04344B1 EE P200100375 A EEP200100375 A EE P200100375A EE P200100375 A EEP200100375 A EE P200100375A EE 04344 B1 EE04344 B1 EE 04344B1
Authority
EE
Estonia
Prior art keywords
preparation
medicament
methods
telmisartan
polymorphs
Prior art date
Application number
EEP200100375A
Other languages
Estonian (et)
Inventor
Schneider Heinrich
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of EE200100375A publication Critical patent/EE200100375A/en
Publication of EE04344B1 publication Critical patent/EE04344B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
EEP200100375A 1999-01-19 2000-01-07 Telmisartan polymorphs, methods for their preparation and their use in the preparation of a medicament EE04344B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19901921A DE19901921C2 (en) 1999-01-19 1999-01-19 Polymorphs of telmisartan, process for their preparation and their use in the manufacture of a medicament
PCT/EP2000/000065 WO2000043370A1 (en) 1999-01-19 2000-01-07 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament

Publications (2)

Publication Number Publication Date
EE200100375A EE200100375A (en) 2002-10-15
EE04344B1 true EE04344B1 (en) 2004-08-16

Family

ID=7894715

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100375A EE04344B1 (en) 1999-01-19 2000-01-07 Telmisartan polymorphs, methods for their preparation and their use in the preparation of a medicament

Country Status (36)

Country Link
EP (1) EP1144386B1 (en)
JP (1) JP4700813B2 (en)
KR (1) KR100658959B1 (en)
CN (1) CN1144790C (en)
AR (1) AR035475A1 (en)
AT (1) ATE252564T1 (en)
AU (1) AU765081B2 (en)
BG (1) BG65027B1 (en)
BR (1) BR0007584A (en)
CA (1) CA2352436C (en)
CO (1) CO5150238A1 (en)
CZ (1) CZ297412B6 (en)
DE (2) DE19901921C2 (en)
DK (1) DK1144386T3 (en)
EA (1) EA003065B1 (en)
EE (1) EE04344B1 (en)
ES (1) ES2208265T3 (en)
HK (1) HK1041485B (en)
HR (1) HRP20010514B1 (en)
HU (1) HU227401B1 (en)
IL (2) IL143634A0 (en)
MY (1) MY122755A (en)
NO (1) NO319823B1 (en)
NZ (1) NZ513528A (en)
PE (1) PE20001362A1 (en)
PL (1) PL211829B1 (en)
PT (1) PT1144386E (en)
RS (1) RS50044B (en)
SA (1) SA99200838B1 (en)
SK (1) SK285429B6 (en)
TR (1) TR200102074T2 (en)
TW (1) TWI280241B (en)
UA (1) UA56358C2 (en)
UY (1) UY25980A1 (en)
WO (1) WO2000043370A1 (en)
ZA (1) ZA200104771B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153737A1 (en) * 2001-10-31 2003-05-28 Boehringer Ingelheim Pharma Crystalline sodium salt of telmisartan, process for its preparation and its use for the manufacture of a medicament
US6737432B2 (en) 2001-10-31 2004-05-18 Boehringer Ingelheim Pharma Kg Crystalline form of telmisartan sodium
AU2002242676B2 (en) * 2002-01-16 2008-05-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof
DE10314702A1 (en) 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for the preparation of telmisartan
GB2414019A (en) * 2004-05-11 2005-11-16 Cipla Ltd One-step preparation of telmisartan by condensation and hydrolysis
CN101039917A (en) 2004-10-15 2007-09-19 特瓦制药工业有限公司 Process for preparing telmisartan
US7943781B2 (en) 2004-10-18 2011-05-17 Dr. Reddy's Laboratories Limited Process for preparing telmisartan
US8637078B2 (en) 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
DE102008059206A1 (en) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic
AR076913A1 (en) 2009-05-20 2011-07-20 Boehringer Ingelheim Vetmed TELMISARTAN DRINK PHARMACEUTICAL SOLUTION. METHOD TO PREPARE THE SOLUTION
PL2443094T3 (en) 2009-06-19 2013-08-30 Krka Tovarna Zdravil D D Novo Mesto Process for the preparation of telmisartan
EP2277866A1 (en) 2009-06-22 2011-01-26 Inke, S.A. Process for preparing telmisartan
EP2448575A2 (en) 2009-07-02 2012-05-09 Bilgic Mahmut Pharmaceutical composition increasing solubility and stability
EP2448576A2 (en) 2009-07-02 2012-05-09 Mahmut Bilgic Solubility enhancing pharmaceutical composition
EA025946B1 (en) 2010-10-27 2017-02-28 Крка, Товарна Здравил, Д. Д., Ново Место Multilayer pharmaceutical composition comprising telmisartan and amlodipine
ITMI20102416A1 (en) * 2010-12-27 2012-06-28 Chemelectiva S R L INTERMEDIATE FOR THE PREPARATION OF AN ACTIVE PRINCIPLE AND PROCESS FOR ITS PREPARATION
EP2612658A1 (en) 2012-01-05 2013-07-10 Laboratorios Lesvi, S.L. Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide
JP6147546B2 (en) * 2013-04-10 2017-06-14 株式会社トクヤマ Method for producing telmisartan A-type crystals with reduced acetic acid
EP2979691A1 (en) 2014-07-30 2016-02-03 Boehringer Ingelheim International GmbH Oral disintegrating tablet
JP6275596B2 (en) * 2014-09-03 2018-02-07 株式会社トクヤマ Method for producing ammonium salt of telmisartan
JP5871294B1 (en) 2015-02-27 2016-03-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Immediate release oral tablets
KR20170001921A (en) 2015-06-26 2017-01-05 대원제약주식회사 A pharmaceutical composition comprising telmisartan with increased stability and a preparation method thereof
KR20170012703A (en) 2015-07-22 2017-02-03 대원제약주식회사 A pharmaceutical composition comprising telmisartan and a preparation method thereof
EP3463309B1 (en) 2016-05-30 2020-06-17 Boehringer Ingelheim International GmbH Fixed dose combination of telmisartan, hydrochlorothiazide and amlodipine
KR102044223B1 (en) * 2016-09-12 2019-11-13 성균관대학교산학협력단 Solid dispersions comprising Telmisartan and the preparation method thereof
CN106749036B (en) * 2016-12-21 2019-06-21 山东大学 Amorphous telmisartan-pimelic acid co-crystal and preparation method and application thereof
CN106749037B (en) * 2016-12-21 2019-06-21 山东大学 Amorphous telmisartan-glutaric acid co-crystal and preparation method and application thereof
ES2979279T3 (en) 2017-07-07 2024-09-25 Boehringer Ingelheim Vetmedica Gmbh Telmisartan for the prophylaxis or treatment of hypertension in cats
CN109851562A (en) * 2019-01-30 2019-06-07 浙江省食品药品检验研究院 A kind of Telmisartan crystal and preparation method thereof
WO2023001880A1 (en) 2021-07-22 2023-01-26 Krka, D. D., Novo Mesto Bilayer tablet comprising telmisartan and indapamide
TW202508593A (en) 2023-05-24 2025-03-01 德商百靈佳殷格翰維美迪加股份有限公司 Combination treatment and/or prevention of cardiac diseases in non-human mammals comprising one or more sglt-2 inhibitors and pimobendan and/or telmisartan
AU2024277852A1 (en) 2023-05-24 2025-10-16 Boehringer Ingelheim Vetmedica Gmbh Combination treatment and/or prevention of renal diseases and/or hypertension in non-human mammals comprising one or more sglt-2 inhibitors and telmisartan
US20250195525A1 (en) 2023-12-15 2025-06-19 Boehringer Ingelheim Vetmedica Gmbh Angiotensin ii receptor antagonist for the prevention of systemic diseases in cats

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9210098B (en) * 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoles, drugs with this compounds, and process for their preparation
US5139114A (en) * 1991-03-18 1992-08-18 Abex Corporation Visible brake block wear indicator

Also Published As

Publication number Publication date
SK10202001A3 (en) 2001-12-03
PE20001362A1 (en) 2000-12-15
UY25980A1 (en) 2001-08-27
YU51101A (en) 2004-05-12
HU227401B1 (en) 2011-05-30
NZ513528A (en) 2003-08-29
HRP20010514A2 (en) 2002-08-31
BG105654A (en) 2002-01-31
BG65027B1 (en) 2006-12-29
AU765081B2 (en) 2003-09-11
EA200100730A1 (en) 2002-02-28
CA2352436A1 (en) 2000-07-27
HUP0105148A3 (en) 2003-01-28
PT1144386E (en) 2004-03-31
AU2288100A (en) 2000-08-07
EP1144386B1 (en) 2003-10-22
HUP0105148A2 (en) 2002-07-29
KR20010101552A (en) 2001-11-14
NO319823B1 (en) 2005-09-19
CA2352436C (en) 2010-03-23
SA99200838B1 (en) 2006-03-06
MY122755A (en) 2006-05-31
NO20013560L (en) 2001-09-18
CO5150238A1 (en) 2002-04-29
ATE252564T1 (en) 2003-11-15
DK1144386T3 (en) 2004-01-12
UA56358C2 (en) 2003-05-15
EE200100375A (en) 2002-10-15
IL143634A (en) 2006-10-05
RS50044B (en) 2008-11-28
TR200102074T2 (en) 2001-12-21
KR100658959B1 (en) 2006-12-19
JP4700813B2 (en) 2011-06-15
CN1336920A (en) 2002-02-20
CN1144790C (en) 2004-04-07
IL143634A0 (en) 2002-04-21
HK1041485B (en) 2004-10-08
HRP20010514B1 (en) 2010-01-31
BR0007584A (en) 2001-11-06
CZ20012634A3 (en) 2001-10-17
ZA200104771B (en) 2002-12-02
DE19901921C2 (en) 2001-01-04
JP2002535315A (en) 2002-10-22
ES2208265T3 (en) 2004-06-16
PL211829B1 (en) 2012-06-29
HK1041485A1 (en) 2002-07-12
AR035475A1 (en) 2004-06-02
DE50004150D1 (en) 2003-11-27
SK285429B6 (en) 2007-01-04
EP1144386A1 (en) 2001-10-17
TWI280241B (en) 2007-05-01
CZ297412B6 (en) 2006-12-13
NO20013560D0 (en) 2001-07-18
EA003065B1 (en) 2002-12-26
WO2000043370A1 (en) 2000-07-27
DE19901921A1 (en) 2000-08-03
PL349425A1 (en) 2002-07-29

Similar Documents

Publication Publication Date Title
EE04344B1 (en) Telmisartan polymorphs, methods for their preparation and their use in the preparation of a medicament
EE200100431A (en) 16-haloepothilone derivatives, process for their preparation and pharmaceutical use
EE04565B1 (en) Adamantane derivatives, their preparation and use
EE200300048A (en) Benzimidazole derivatives, their preparation and therapeutic use
EE04236B1 (en) Benzimidazoles, their preparation and use as medicaments
EE200200064A (en) Arylmethylcarbonylaminothiazole derivatives, their preparation and their use as anticancer agents
EE200100470A (en) Pyridopyranoazepine derivatives, their preparation and therapeutic use
EE200100684A (en) Indalyl-substituted benzenecarboxamides, process for their preparation, use and pharmaceutical compositions
NO2013004I2 (en) Axitinib, optionally in the form of a pharmaceutical accentible salt
EE200200602A (en) Long-acting beta-mimetics, a process for their preparation and their use as medicaments
EE200000037A (en) Acylpiperazinylpyrimidines Derivatives, Their Preparation and Use as Medicaments
EE04721B1 (en) Phenylxanthine derivatives, processes for their preparation and use
EE05000B1 (en) 2'-Substituted 1,1'-biphenyl-2-carboxamides, their use and pharmaceutical preparations
EE200300193A (en) Substituted benzimidazoles, their use and medicine
EE200100422A (en) Epothilone derivatives, process for their preparation and pharmaceutical use
EE200100615A (en) A microgranule, a process for its preparation and a pharmaceutical preparation
HUP0201810A3 (en) Sootepenseone and its derivatives, their preparation and use as medicament
NO20015104L (en) New pharmaceutical preparation
EE04837B1 (en) Echinocandin derivatives, process for their preparation and use as antimycotics
EE200000018A (en) 6-Pyrrolidin-2-ylpyridines, their Preparation and Therapeutic Use
EE200200266A (en) 2-Arylquinoline derivatives, their preparation and use in pharmaceuticals
EE9900560A (en) 5-Naphthalen-1-yl-1,3-dioxane derivatives, their preparation and therapeutic use
SI1144386T1 (en) Telmisartan polymorphs, procedures for their preparation and their use in the preparation of the product
FI991396A0 (en) 5-substituted 3-hydroxybenzoates, process for their preparation and their use
IT1312082B1 (en) MORPHINOID DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC USE.

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20150107